BlackRock LifePath® Index 2030 Fund Institutional Shares
LINIX
NASDAQ
Weiss Ratings | LINIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Reward Grade | C | |||
Risk Index | Fair | |||
Risk Grade | C | |||
Company Info | LINIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Provider | BlackRock | |||
Manager/Tenure (Years) | Christopher Chung (5), Michael Pensky (0), Peter Tsang (0) | |||
Website | http://www.blackrock.com | |||
Fund Information | LINIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Fund Name | BlackRock LifePath® Index 2030 Fund Institutional Shares | |||
Category | Target-Date 2030 | |||
Sub-Category | Target Date | |||
Prospectus Objective | Asset Allocation | |||
Inception Date | May 31, 2011 | |||
Open/Closed To New Investors | Open | |||
Minimum Initial Investment | 2,000,000.00 | |||
Minimum Subsequent Investment | -- | |||
Front End Fee | -- | |||
Back End Fee | -- | |||
Dividends and Shares | LINIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield | 2.57% | |||
Dividend | LINIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield (Forward) | 2.11% | |||
Asset Allocation | LINIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash | 1.27% | |||
Stock | 48.59% | |||
U.S. Stock | 30.08% | |||
Non-U.S. Stock | 18.51% | |||
Bond | 47.27% | |||
U.S. Bond | 44.77% | |||
Non-U.S. Bond | 2.50% | |||
Preferred | 0.00% | |||
Convertible | 0.00% | |||
Other Net | 2.87% | |||
Price History | LINIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -0.21% | |||
30-Day Total Return | 1.79% | |||
60-Day Total Return | 2.47% | |||
90-Day Total Return | 5.53% | |||
Year to Date Total Return | 9.61% | |||
1-Year Total Return | 9.21% | |||
2-Year Total Return | 26.14% | |||
3-Year Total Return | 33.71% | |||
5-Year Total Return | 37.24% | |||
Price | LINIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Closing Price | -- | |||
1-Month Low Price | -- | |||
1-Month High Price | -- | |||
52-Week Low Price | -- | |||
52-Week Low Price (Date) | -- | |||
52-Week High Price | -- | |||
52-Week High Price (Date) | -- | |||
NAV | LINIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Nav | $18.73 | |||
1-Month Low NAV | $18.32 | |||
1-Month High NAV | $18.79 | |||
52-Week Low NAV | $16.18 | |||
52-Week Low NAV (Date) | Apr 08, 2025 | |||
52-Week High NAV | $18.79 | |||
52-Week High Price (Date) | Aug 28, 2025 | |||
Beta / Standard Deviation | LINIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.68 | |||
Standard Deviation | 11.32 | |||
Balance Sheet | LINIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Total Assets | 13.03B | |||
Operating Ratios | LINIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Expense Ratio | 0.14% | |||
Turnover Ratio | 26.00% | |||
Performance | LINIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Last Bull Market Total Return | 11.73% | |||
Last Bear Market Total Return | -11.42% | |||